• Mashup Score: 5

    AuthorsGeorge R. SimonH. Lee Moffitt Cancer Center and Research Institute, Celebration, FLGeorge R. Simon, Petr Jordan, Chiharu Sako, Ryan Beasley, Dwight Hall Owen, Arpan Patel, Brendan D. Curti, Roshanthi K. Weerasinghe, Soohee Lee, Arya Amini, An Liu, Ray D. Page, Aurélie Swalduz, Jean-Paul Beregi, Stéphane Sanchez, Olivier Gevaert, Ravi Bharat Parikh, Hugo AertsOrganizationsH. Lee Moffitt…

    Tweet Tweets with this article
    • At #ASCO23, Moffitt's Dr. George R. Simon joined us for a discussion on AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response. Learn more ➡️ https://t.co/EycYeCZplk #MoffittASCO23 @ASCO https://t.co/ZVRb5rsYeo

  • Mashup Score: 3

    AuthorsHumaira SarfrazH. Lee Moffitt Cancer Center and Research Institute, Tampa, FLHumaira Sarfraz, Shahla Bari, Krupal Patel, Tumpa Dutta, Stephen Gardell, Karen Corbin, Heather S.L. Jim, Shaliz Aflatooni, Aleena Boby, Nicole Natarellin, Tien Nguyen, Jose Conejo-Garcia, Jameel MuzaffarOrganizationsH. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, Moffitt Cancer Center, Tampa, FL,…

    Tweet Tweets with this article
    • Dr. @HumairaSarfraz2 joined us for a discussion on safety & efficacy of time restricted eating in improving response to immunotherapy in head & neck cancer patients while at #ASCO23. Learn more ➡️ https://t.co/RoriMJwPqI #MoffittASCO23 @ASCO https://t.co/EY3BVSn6RR

  • Mashup Score: 4

    ASCO-SEP 2022 Digital SubscriptionA comprehensive program for your self-assessment needs includes all-digital SEP® content (22 chapters + more chapter questions), an updated Question Bank, and additional educational resources. Subscribe today!

    Tweet Tweets with this article
    • While at #ASCO23: Moffitt's Robin Park (@rprobinpark) discusses clinical outcomes in patients with recurrent/metastatic head and neck squamous cell carcinoma. Learn more ➡️ https://t.co/0mYyyozZCM #MoffittASCO23 @ASCO https://t.co/WLoAopMznv

  • Mashup Score: 3

    ASCO-SEP 2022 Digital SubscriptionA comprehensive program for your self-assessment needs includes all-digital SEP® content (22 chapters + more chapter questions), an updated Question Bank, and additional educational resources. Subscribe today!

    Tweet Tweets with this article
    • Live from #ASCO23: @KarnavModi, a visiting research scholar, discusses the latest in multiple myeloma symptoms and survivorship. Learn more ➡️ https://t.co/uWqIrjR3n6 #MoffittASCO23 @ASCO https://t.co/pHZRtzS4Ul

  • Mashup Score: 3

    AuthorsDoris K. HansenDepartment of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FLDoris K. Hansen, Krina K. Patel, Lauren C. Peres, Mehmet H. Kocoglu, Leyla Shune, Gary Simmons, Christopher J. Ferreri, Shebli Atrash, Ricardo Daniel Parrondo, Saurabh Chhabra, Patrick Costello, Shonali Midha, Melissa Alsina, Peter M. Voorhees, Myo Htut, Douglas W. Sborov,…

    Tweet Tweets with this article
    • Live from #ASCO23: Dr. Doris Hansen joins us for a discussion on Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM). Learn more ➡️ https://t.co/K6obs0ZD79 #MoffittASCO23 @ASCO https://t.co/ANuotk9cVV

  • Mashup Score: 0

    AuthorsLuis E. AguirreH. Lee Moffitt Cancer Center and Research Institute, Tampa, FLLuis E. Aguirre, Akriti Gupta Jain, Somedeb Ball, Najla Al Ali, David Andrew Sallman, Andrew Tucker Kuykendall, Onyee Chan, Zhuoer Xie, Alison R. Walker, Kendra Lynn Sweet, Jeffrey E. Lancet, Eric Padron, Rami S. KomrokjiOrganizationsH. Lee Moffitt Cancer Center and Research Institute, Tampa, FLAbstract…

    Tweet Tweets with this article
    • LIVE from #ASCO23: Dr. Luis Aguirre’s (@LeafOnc) abstract on “Refining risk stratification in CMML: A comprehensive assessment of the IPSS-M and other molecularly informed models” is presented. Learn more ➡️ https://t.co/lhRk2vAzgN #ASCO23 #MoffittASCO23 @ASCO https://t.co/Qx5WutP9f5

  • Mashup Score: 4

    AuthorsAndreas Nicholas SaltosMoffitt Cancer Center, Tampa, FLAndreas Nicholas Saltos, Christy Arrowood, Georgia Beasley, James Ronald, Ghassan El-Haddad, Luiziane Guerra-Guevara, Uzma Khan, Steven Wolf, Lin Gu, Xiaofei F. Wang, Dana Foresman, Xiaoqing Yu, Mark J. Cantwell, Scott Joseph Antonia, Amer A Beg, Neal E. ReadyOrganizationsMoffitt Cancer Center, Tampa, FL, Duke University Medical…

    Tweet Tweets with this article
    • President and CEO @PatrickHwuMD joined Dr. Andreas Saltos to discuss the abstracts he's presented while at #ASCO23. #MoffittASCO23 1️⃣ Abstract 2569: https://t.co/vm6QExtWFc 2️⃣ Abstract 9125: https://t.co/H5wC8rsDyi https://t.co/Cx3aq6Vikt

  • Mashup Score: 1

    ASCO-SEP 2022 Digital SubscriptionA comprehensive program for your self-assessment needs includes all-digital SEP® content (22 chapters + more chapter questions), an updated Question Bank, and additional educational resources. Subscribe today!

    Tweet Tweets with this article
    • Dr. Luis Aguirre (@LeafOnc) joined President and CEO @PatrickHwuMD at #ASCO23 for a discussion on refining risk stratification in CMML. Learn more ➡️ https://t.co/YTrwTSFWQX #MoffittASCO23 @ASCO https://t.co/hWIlPyGGn8

  • Mashup Score: 0

    AuthorsRicardo L CostaH. Lee Moffitt Cancer Center and Research Institute, Tampa, FLRicardo L Costa, Jennifer A Childress, Edith Abraham, Carly Farrell, Qianxing Mo, Zena Jameel, Aixa Elena Soyano Muller, Kimberley T Lee, Susan Hoover, John Kiluk, Robert J Weinfurtner, Marie Catherine Lee, Christine Laronga, Nazanin Khakpour, Hyo S. Han, Hung T. Khong, Hatem Hussein Soliman, Brian J….

    Tweet Tweets with this article
    • At #ASCO23, Dr. Ricardo Costa joined us for a discussion the DecipHER trial. Learn more ➡️ https://t.co/OA669ZwVFg #MoffittASCO23 @ASCO https://t.co/hGoHaLytNw

  • Mashup Score: 3

    ASCO-SEP 2022 Digital SubscriptionA comprehensive program for your self-assessment needs includes all-digital SEP® content (22 chapters + more chapter questions), an updated Question Bank, and additional educational resources. Subscribe today!

    Tweet Tweets with this article
    • Moffitt's Dr. @BrunaPellini joined us to discuss circulating tumor DNA monitoring to inform maintenance outcomes in patients with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel. Learn more ➡️ https://t.co/LlyrZcVdwX #MoffittASCO23 #ASCO23 @ASCO https://t.co/X1UORloRGZ